The Market Reports

Synopsis
The global market for Multilayer Co-extruded Film Infusion Bags was estimated to be worth US$ 1791 million in 2024 and is forecast to a readjusted size of US$ 2326 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Multilayer Co-extruded Film Infusion Bags cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Multilayer co-extruded film infusion bags are packaging containers for infusions. They are made by co-extruding different high-performance polymer materials into a structure usually consisting of 3 or 5 layers. The inner layer is in contact with the medicinal liquid and is made of medical-grade polyolefin materials. The barrier layer can prevent the entry of oxygen and water vapor. The reinforcing layer improves mechanical strength, and the outer layer has good wear - resistance and printability. These bags have excellent properties such as good barrier performance, high chemical stability, and excellent mechanical properties, ensuring the safety and stability of the medicinal liquid. This report only counts empty infusion bags that do not contain pharmaceutical liquids.
The global market for multilayer co-extruded film infusion bags is being driven primarily by the rising demand for non-PVC, biocompatible, and environmentally safer alternatives to traditional PVC-based infusion systems. These advanced film materials, often composed of polyolefin (PP/PE), EVOH, or other thermoplastics, offer excellent chemical resistance, thermal stability, and transparency, which make them ideal for a variety of intravenous (IV) therapies. Growing awareness of the potential health risks associated with DEHP-plasticized PVC bags—especially their leaching of phthalates—has prompted stringent regulatory action in regions like the EU, China, and the United States. Additionally, as the global population ages and chronic disease incidence rises, hospitals and healthcare providers are increasing their usage of infusion therapies, thus expanding the demand for reliable, lightweight, and durable infusion packaging. Pharmaceutical companies are also benefiting from the longer shelf life and reduced contamination risks that multilayer co-extruded films provide, especially for sensitive drug formulations and parenteral nutrition.
Despite the clear advantages, the multilayer co-extruded film infusion bag market faces several challenges that could hamper its growth. One major barrier is the relatively high production cost associated with advanced multilayer films, due to the complexity of co-extrusion processes and the need for specialized raw materials like EVOH and cyclic olefin polymers (COP). This makes non-PVC infusion bags more expensive than their traditional counterparts, limiting adoption in cost-sensitive markets or public healthcare systems with tight budgets. Another challenge lies in compatibility and regulatory hurdles—different drug formulations may interact differently with multilayer films, requiring exhaustive stability testing and regulatory approvals, which increase time-to-market for drug manufacturers. Furthermore, the manufacturing infrastructure and equipment needed for producing and filling these bags are not universally standardized, leading to potential bottlenecks for new entrants. These factors, combined with strong competition from established PVC-based bag manufacturers, pose a constraint on faster market penetration.
This report aims to provide a comprehensive presentation of the global market for Multilayer Co-extruded Film Infusion Bags, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Multilayer Co-extruded Film Infusion Bags by region & country, by Capacity, and by Application.
The Multilayer Co-extruded Film Infusion Bags market size, estimations, and forecasts are provided in terms of sales volume (Million Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multilayer Co-extruded Film Infusion Bags.
Market Segmentation
By Company
Baxter
SSY Group
B.Braun
Fresenius Kabi
ICU Medical
Otsuka
Technoflex
Spirit Medical
Valmed
Sippex
CR Double-Crane
Huaren Pharmaceutical
Cisen Pharmaceutical
Sichuan Kelun Pharmaceutical
Chimin Health
Shandong Hualu Pharmaceutical
Segment by Capacity
250ml
100ml
50ml
500ml
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Multilayer Co-extruded Film Infusion Bags manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Capacity, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Multilayer Co-extruded Film Infusion Bags in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Multilayer Co-extruded Film Infusion Bags in country level. It provides sigmate data by Capacity, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index